Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 704 (USA) (Dr. Tanaka)
· consented 2014-05-11
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
severe
assessed
2026-08-18
Severe COMPLETED SUICIDE — outcome: FATAL; onset 2014-10-31 (study day 174.0); relationship: NONE; serious criteria: death
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.